This trial will help assess if a certain kind of liver cell can be used to help diagnose non-alcoholic fatty liver disease and its severity.
3 Primary · 0 Secondary · Reporting Duration: two years
100 Total Participants · 1 Treatment Group
Primary Treatment: Liver Incytes · No Placebo Group · N/A
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: